Addison Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Addison Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-158	Closed	-$1.95K	–	885
2024 Q4	$1.95K	Hold	158	–	–	﹤0.01%	751
2024 Q3	$1.8K	Hold	158	–	–	﹤0.01%	744
2024 Q2	$1.13K	Hold	158	–	–	﹤0.01%	716
2024 Q1	$1.06K	Hold	158	–	–	﹤0.01%	645
2023 Q4	$1.03K	Hold	158	–	–	﹤0.01%	656
2023 Q3	$1.49K	Hold	158	–	–	﹤0.01%	603
2023 Q2	$2.21K	Hold	158	–	–	﹤0.01%	562
2023 Q1	$2.96K	Hold	158	–	–	﹤0.01%	540
2022 Q4	$2.18K	Hold	158	–	–	﹤0.01%	552
2022 Q3	$3K	Hold	158	–	–	﹤0.01%	550
2022 Q2	$2K	Hold	158	–	–	﹤0.01%	562
2022 Q1	$3K	Hold	158	–	–	﹤0.01%	569
2021 Q4	$5K	Hold	158	–	–	﹤0.01%	477
2021 Q3	$3K	Hold	158	–	–	﹤0.01%	370
2021 Q2	$4K	Buy	+158	New	+$3.38K	﹤0.01%	353
2020 Q4	$2K	Buy	+158	New	+$1.44K	﹤0.01%	360

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Addison Advisors's CDMO Position: Q1 2025 in Review

Addison Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 158 shares — an estimated $1.95K sold.

Addison Advisors first reported a position in CDMO in Q4 2020 and held it in 16 quarters. The position peaked at $5K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Addison Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Addison Advisors sold 158 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.95K.
Addison Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
Addison Advisors's Avid Bioservices, Inc. Common Stock position peaked at $5K in Q4 2021.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Addison Advisors's 13F filing for Q1 2025, filed 12 May 2025.